HMS, Department of Health Care Policy

Speaker: Mai Pham, MD, MPH, Vice President, Provider Alignment Solutions, Anthem, Inc.

HMS, Tosteson Medical Education Center, Room 227

Luxturna, a gene therapy treatment for a rare form of inherited blindness, was recently approved and administered for the first time to a patient at Massachusetts Eye and Ear Hospital in early 2018 at a cost of $850,000. How should patients, physicians, and the US health care system approach a new generation of gene therapies that offer substantial clinical promise and are made available at such price levels? How do we maximize “health gain” with available resources across the entire population?

Join more than 300 HBS alumni in San Francisco on Sunday, January 6, 2019 at the Bluestem Brasserie Restaurant. Kick off the start of the 37th annual JP Morgan Health Care Conference with cocktails and networking. Registration is required.

Virtual

Speaker: Meghan M. FitzGerald, Ph.D., DrPH, Associate Professor, Health Policy and Management, Mailman School of Public Health, Columbia University. Meghan Fitzgerald will discuss her experiences in core roles from big pharma and bio tech to her current position at Columbia's School of Public Health.

HLS, Wasserstein Hall, Milstein East

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.